Dystrophin is the protein product which is absent in Duchenne muscular dystrophy (DMD). In mammalian skeletal muscle, dystrophin is found in association with several integral and peripheral membrane proteins, forming a complex known as the dystrophin glycoprotein complex (DGC). In an expressed sequence tag (EST) database search to identify new dystrophin related genes, we isolated EST00891 which showed 57% homology to the cysteine-rich domain of dystrophin and localized to 18q12.1-12.2. This EST is also highly homologous (90%) to the Torpedo californica post-synaptic 87 kDa phosphoprotein. Screening human adult brain and skeletal muscle cDNA libraries with this EST resulted in cloning multiple cDNAs which encode several splice forms all homologous to the Cterminal domain of dystrophin. The largest open reading frame isolated shows 94% homology (86% identity) to the Torpedo 87 kDa protein and 50% homology to the cysteine-rich and carboxy-terminal domains of dystrophin. The other cDNAs isolated encode smaller splice forms of this gene which we have named dystrobrevin. The tissue distribution of dystrobrevin mRNA shows five distinct transcripts which are preferentially expressed between different tissues. In addition, antibodies against either the Torpedo 87 kDa protein or human dystrobrevin demonstrate that at least three of the splice forms are translated as proteins in human brain tissue extracts.
INTRODUCTION
Dystrophin is the protein product of the Duchenne muscular dystrophy (DMD) locus which is absent in DMD (1) . It is a membrane-associated cytoskeletal protein and a member of the spectrin superfamily of actin-binding proteins (2) . It localizes to the cytoplasmic surface of the sarcolemma in normal skeletal muscle (3) (4) (5) where it is thought to participate in the stabilization of the membrane during muscle contraction and relaxation (6) . Dystrophin has been found in many organisms and tissues, including the electric organ of the Torpedo californica (7) . The electrogenic cells that make up the electric organ of Torpedo are derived embryologically from immature striated muscle cells, and therefore retain many biochemical similarities to mammalian skeletal muscle. When dystrophin is purified from Torpedo electric organ, it is found in association with two proteins of 58 kDa and 87 kDa (8) (9) (10) (11) . The 58 kDa protein and its mammalian homologues, the syntrophins, have been cloned and characterized (12) (13) (14) , and have been shown to directly interact with dystrophin (15, 16) .
The Torpedo 87 kDa protein was recently cloned as cDNA which was found to encode a predicted 725 amino acids protein of 82 037 daltons (17) . Its 4.6 kb mRNA transcript is expressed in electric organ, muscle and brain, but is present several fold more abundantly in the electric organ. No 87 kDa transcript was detected in liver, intestine, heart or blood (17) . The deduced 726 amino acids sequence for the 87 kDa protein predicts a hydrophilic protein with four potential sites for tyrosine phosphorylation in the C-terminal 148 amino acids, consistent with its isolation as a phosphoprotein in the Torpedo electric organ. There is significant homology to the cysteine-rich (CR) and the C-terminal (CT) domains of dystrophin with an overall 27% amino acid identity. The function of the CR domain of dystrophin is unknown, but it encodes potential divalent metal-binding sites which are known to be present in proteins forming oligomeric structures. In the CT domain of both proteins, a heptad repeat of leucines with no intervening proline is conserved. Such leucine motifs are found in proteins that form homo-and hetero-dimers. Therefore, this heptad repeat may be the basis for interactions between 87 kDa and dystrophin with other proteins or among themselves (17) .
In mammalian skeletal muscle, dystrophin is found in association with several integral and peripheral membrane proteins, forming a complex which is now referred to as the dystrophin glycoprotein complex (DGC) (18) (19) (20) . The DGC binding site is located on the CR region and the first half of the CT domain of dystrophin (21, 22) . Also copurifying with the DGC are the syntrophins of 59 kDa homologous to the Torpedo 58 kDa protein, as well as a minor component at 94 kDa (A 0 ) (18, 20) which based upon the amino acid sequence of the rabbit A 0 appears to be the mammalian homologue of the Torpedo 87 kDa protein (23) . Given this homology and the potential role in the dystrophin-associated glycoprotein (DAG) complex, we attempted to identify the human homologue of the Torpedo 87 kDa protein. In addition, the human gene might be involved in human genetic disease much like other DAG proteins, α-sarcoglycan (50 DAG, adhalin) (24), β-sarcoglycan (43 DAG) (25, 26) and γ-sarcoglycan (35 DAG) (27) .
The human homologue of the Torpedo 87 kDa protein was found by searching the EST database for homology with the entire dystrophin sequence. Originally, EST00891 was retrieved and was localized to chromosome 18q12.1-12.2 by fluorescence in situ hybridization (FISH) analysis (28) . Here, we report the identification and characterization of cDNAs encoding multiple splice forms of this gene whose protein we named dystrobrevin for it encodes proteins of various sizes with homology to the C-terminal of dystrophin. Dystrobrevin transcripts are strongly expressed in brain, skeletal and cardiac muscles, and expressed at lower levels in lung, liver and pancreas. Using a monoclonal antibody against the Torpedo dystrobrevin protein and an anti-peptide antibody raised against the human sequence, we have demonstrated that at least three splice forms are translated in proteins in human brain tissue extracts. The three protein sizes (80 kDa, 62 kDa, 50 kDa) correlate with the predicted sizes calculated from isolated cDNAs.
RESULTS
In an expressed sequence tag (EST) database search with various domains of dystrophin sequence as an electronic probe, the EST00891 was retrieved (Fig. 1A ) whose deduced amino acid sequence has 56.5% homology (41% identity) over a 46 amino acids stretch of the CT domain of dystrophin (28) . It is also highly homologous (90%) to the Torpedo post-synaptic 87 kDa phosphoprotein (data not shown) (17) . Hybridization of a brain cDNA library with the EST00891 resulted in the isolation of a 1.7 kb cDNA clone (28) . This clone was sequenced (Fig. 1B) and the 1729 bp sequence encodes a single open reading frame of 1122 bp, predicted to start from the first initiator ATG embedded in a Kozak consensus sequence at the 5′ end of the transcript. There are three in-frame stop codons 5′ of the methionine codon, and three in-frame stop codons directly 3′ of the terminating codon. In spite of the high degree of deduced amino acid identity (82%) between the human cDNA and the Torpedo 87 kDa sequence (Fig. 1B) , the human cDNA encodes a protein that is approximately half the size of the Torpedo 87 kDa protein missing the C-terminal 374 amino acids of the Torpedo 87 kDa. The calculated molecular mass of the deduced protein which we named dystrobrevin is 42 kDa.
To investigate the relative amounts of expression of the dystrobrevin transcript in different human tissues, northern blot analysis was done using hybridization probe 89A which corresponds to the 5′ end of the open reading frame in the sequenced 1.7 kb cDNA (see Materials and Methods). Five distinct transcripts ( Fig. 2A) were observed: a 6.5 kb and a 5.1 kb transcript expressed in brain, lung, liver, skeletal muscle, and pancreas; a 4 kb transcript expressed only in skeletal muscle; a 3.4 kb and a 2.2 kb transcript expressed in cardiac muscle as well as in brain, lung, liver, skeletal muscle, and pancreas. Among the tissues tested, human brain and skeletal muscle had the highest level of transcripts followed by cardiac muscle, although the 2.2 kb transcript was primarily expressed in cardiac and skeletal muscles. Lung, liver and pancreas had substantially lower levels of the 6.5 kb, 5.1 kb, 3.4 kb, and 2.2 kb transcripts, and no detectable 4 kb transcript. No transcript of any size was detected in kidney, or placenta.
In order to understand the nature of the alternative transcript signals detected, additional cDNAs homologous to dystrobrevin were isolated and characterized from human adult skeletal muscle and brain libraries using three different regions of the 1.7 kb cDNA as hybridization probes. Six different cDNAs were obtained multiple times. As all the cDNAs isolated had complete open reading frames and therefore correspond to a splice form of the human homologue of the Torpedo 87 kDa protein, we decided to name the cDNA clones in descending size, starting with dystrobrevin-α being the largest open reading frame. Figure 3 and Table 1 summarize the different splice forms that we have identified. Three cDNAs each of 3.5 kb were obtained which encode a single open reading frame of 2058 bp starting from the same initiator ATG codon but without the stop codon found in the original dystrobrevin clone, and with additional open reading frame before a clear stop codon (Fig. 4) . The open reading frame predicts a deduced peptide of 686 amino acids in length with a predicted molecular weight of 80 kDa. Since this is the largest open reading frame isolated, we named this form dystrobrevin-α. Dystrobrevin-α has high homology to Torpedo 87 kDa both at the nucleotide (75% identity) and the amino acid level (93% homologous with 84% identity); we therefore refer to the Torpedo 87 kDa protein as Torpedo dystrobrevin. This degree of semblance correlates well with the similarity found between human and Torpedo dystrophins which are 87% similar and 77% identical. Much like dystrophin, the Torpedo dystrobrevin CR domain also contains a high number of cysteines (12 residues) although their exact positions are not conserved. These same cysteines are also found in human dystrobrevin-α (see boxed residues Fig. 4 ). Within the region homologous to the CT domain of dystrophin, the identical leucine residues composing the predicted heptad repeats of dystrophin and Torpedo dystrobrevin are also found in dystrobrevin-α (see underlined residues, Fig. 4 ). The C-terminal 100 amino acids diverge from dystrophin sequence and are unique to the Torpedo and human dystrobrevin protein. Despite the overall high homology, the dystrobrevin-α differs greatly from Torpedo dystrobrevin in two regions ( Fig. 3) : a region from amino acids 360 to 366 (corresponding to amino acids 353-389 in the Torpedo 87 kDa protein, and exons 72-73 in dystrophin), and a second region from amino acids 499 to 506 (corresponding to amino acids 515-531 in Torpedo dystrobrevin and the end of dystrophin's exon 75). Interestingly, both divergences occur at sites where alternative splice forms dystrobrevin-δ and dystrobrevin-β (discussed below) diverge respectively. The corresponding transcript size deduced from northern analysis with different 3′ ends as hybridization probes and the length of the open reading frame are shown. The calculated molecular weight of the deduced proteins are also shown.
In addition to dystrobrevin-α and the initially cloned -δ, four additional splice forms of dystrobrevin were identified in multiple isolated cDNAs: dystrobrevin-β, dystrobrevin-γ, dystrobrevin-ε and dystrobrevin-ζ (Table 1 and Fig. 3 ). The dystrobrevin-β encodes a single open reading frame 577 deduced amino acids with a predicted molecular weight of 65 kDa. The dystrobrevin-γ encodes a single open reading frame of 1539 bp corresponding to a deduced amino acid sequence of 513 amino acids with a predicted molecular weight of 59 kDa. Both dystrobrevin-β and -γ have the same 5′ end of dystrobrevin-α, but are truncated forms in that they diverge from dystrobrevin-α and Torpedo dystrobrevin at amino acid 552 with a final exon encoding a distinct 13 amino acids before a clear stop codon and a different 3′ UTR (Fig. 3) . Dystrobrevin-γ differs from dystrobrevin-β in that it does not encode the region homologous to dystrophin's exons 72 and 73. Dystrobrevin-ε and dystrobrevin-ζ encode a deduced amino acid sequence of 391 and 192 respectively. In contrast to all the other splice forms isolated, both dystrobrevin-ε and dystrobrevin-ζ have a translational start point at amino acid 319 within the other dystrobrevin splice forms. Both dystrobrevin-ε and -ζ differ from each other in their 3′ end and an internal region (Fig. 3) .
To support the existence of these splice forms, we used the EST database to align a contig of the existing ESTs (Fig. 4B) from the public database. To further document their actuality, each of the splice forms were amplified by PCR using reverse transcribed brain cDNA as the template (see Materials and Methods), utilizing primers derived from the unique sequences of each of the splice forms (data not shown). To try to correlate which splice form is encoded by which size transcript, we further analyzed the tissue distribution of the different splice forms by designing and using hybridization probes that are specific for each splice form. This would address the sizes of 3′ and 5′ untranslated regions which were not present in the original cDNA clones. A hybridization probe specific for the 3′ UTR of the largest form, dystrobrevin-α and of dystrobrevin-ε, detects the 6.5 kb transcript which is expressed in high abundance in brain and skeletal muscle as well as the 2.2 kb transcript expressed in heart and skeletal muscle (Fig. 2B) . A hybridization probe specific for the 3′ UTR of the original cloned dystrobrevin-δ, detects the 2.2 kb transcript specifically expressed in high abundance in cardiac and skeletal muscles (Fig. 2D) . A hybridization probe specific for the 3′ UTR of dystrobrevin-β, -γ, and -ζ detects the 5.1 kb transcript expressed in brain and skeletal muscle as well as the 3.4 kb and 2.2 kb transcripts expressed in addition in cardiac muscle (Fig.  2C) . Therefore, we believe that the originally detected 2.2 kb transcript ( Fig. 2A) is composed of a triplet of dystrobrevin-δ, dystrobrevin-ε, and dystrobrevin-ζ.
To determine if the alternative RNA splice forms are expressed as proteins, two different antibodies, a monoclonal against Torpedo dystrobrevin, 24H3 (epitope unknown) (9) and an anti-peptide polyclonal antibody (Ab PEP89) directed against a seventeen amino acid peptide located at the 5′ end of human dystrobrevin-α, -β, -γ and -δ (see Materials and Methods) were used on immunoblots. The polyclonal antibody was against a peptide designed to recognize the largest dystrobrevin, dystrobrevin-α, as well as proteins produced from the alternative splice forms containing the 5′ end of the dystrobrevin (splice form β, γ, and δ, see Fig. 3 ). Furthermore, we expected this antibody to cross react with Torpedo dystrobrevin given the high degree of identity for this region (94%). Ab PEP89 specifically recognized the peptide that was used as an antigen (data not shown), a bacterially expressed fusion protein that produces the N-terminus of dystrobrevin (data not shown), and the 87 kDa protein present in purified Torpedo membrane extracts (Fig. 5, lane 3) . It became apparent during our analysis that the peptide antibody (Ab PEP89) recognizes skeletal muscle myosin probably due to a four amino acids overlap between the peptide sequence and muscle myosin. This cross reactivity precludes its use as an antibody against muscle tissues. However, Ab PEP89 does not appear to detect non-muscle myosin in brain. An alternative to the specific human antibody was the monoclonal against Torpedo dystrobrevin (9) .
On immunoblots, the anti-human-dystrobrevin antibody (AB89) detects three bands in tissue extracts from normal brain corresponding to molecular weights of 80, 62 and 50 kDa (Fig. 5, lane 1) . The sizes approximately correspond to the expected sizes of the dystrobrevin-α, -β and -γ, and -δ, respectively ( Table 1 ). The higher abundance of the 62 kDa band is presumably due to the presence of both dystrobrevin-β and -γ which are too close in molecular weight to be resolved by the 10% acrylamide. No proteins of any size were detected in placenta tissue extract (Fig. 5, lane 2) consistent with the RNA analysis ( Fig. 2A) . To confirm the specificity of the anti-human-dystrobrevin antibody, immunoblots were performed using the monoclonal antibody against Torpedo dystrobrevin on the same tissue extracts samples. Again, three bands corresponding to 80 kDa, 62 kDa and 50 kDa proteins were detected in tissue extracts from brain (Fig. 5, lane 4) , while no proteins of any size were detected in tissue extracts from placenta (Fig. 5, lane 5) . Therefore, at least three, and possibly four of the isolated splice forms of dystrobrevin were detected as proteins. In addition to the three intense bands detected in the brain tissue extract, the anti-peptide antibody detects a faint band at size 87 kDa. This presumably corresponds to another splice form resembling dystrobrevin-α but encoding exon 72 and 73, although we have not yet isolated the cDNA for this new splice form. Not unexpectedly, the antipeptide antibody did not detect the two smaller splice forms, dystrobrevin-ε and dystrobrevin-ζ, since they do not encode the peptide sequence. Since the monoclonal against Torpedo dystrobrevin did not detect these two splice forms, its epitope is presumably in the same 5′ region as the anti-peptide antibody.
DISCUSSION
The human homologue of the 87 kDa Torpedo electric organ derived post-synaptic protein shares some features with the Torpedo protein, but also has significant differences. Like Torpedo dystrobrevin, the largest human dystrobrevin form (dystrobrevin-α) encodes the CR and CT domains homologous to those found in dystrophin. But unlike what is seen in Torpedo, there are different splice forms which encode different domains of the protein. The tissue distribution on northern blots of human dystrobrevin revealed the existence of five distinct transcripts which show differences in their expression pattern. The largest 6.5 kb transcript, corresponding to the largest open reading frame, dystrobrevin-α, is expressed at high abundance in brain and skeletal muscle. Dystrobrevin-α is the most similar to Torpedo 87 kDa as it encodes a protein containing all three domains (CR, CT and unique C-terminal). It has 54% similarity with 31% identity to dystrophin in these domains, thereby making it a member of the dystrophin related family of proteins. In addition, the C-terminus of dystrobrevin-α, the largest predicted protein, contains the region homologous to the unique C-terminal domain of Torpedo dystrobrevin. This region encodes the tyrosine residues which are thought to be phosphorylated in the Torpedo electric organ, and suggests that dystrobrevin-α might also be a phosphoprotein. The predicted size is 77572 daltons, and on immunoblot an antipeptide antibody raised against the human sequence as well as a monoclonal antibody against Torpedo dystrobrevin detect a protein of molecular weight 80 kDa which correlates with this expected size. Dystrobrevin-α differs from Torpedo dystrobrevin, however, as it does not encode the region homologous to dystrophin's exons 72 and 73. We believe that the faint 87 kDa band that we detect on western blot is the full length dystrobrevin encoding these two exons not yet isolated. Five other splice forms have been isolated which fall into two categories. The first class, dystrobrevin-β, -γ, and -δ, are alternatively spliced in the 3′ end of the gene making truncated forms of full length dystrobrevin. The second class, dystrobrevin-ε and -ζ differ from the other forms in their 5′ start site (Fig. 3) .
By comparison of sites of sequence divergence between the different human splice forms and the dystrophin sequence, it is possible to predict positions of alternative splicing and hence intron/exon borders. At least seven of fifteen intron/exon borders appear to be conserved by this analysis (Fig. 3) . The unique 23 amino acids 5′ end of dystrobrevin-α, -β, -γ, and -δ starts at the cysteine-rich conserved domain exactly at the 5′ end point of dystrophin exon 64. Two splice forms β and ε have divergence breakpoints in the region homologous to dystrophin exon 72-73, and these divergence points indicate that borders between exons 71, 72, 73, 74 are conserved. These are the same exons known to be alternatively spliced in dystrophin (29) . At the unique 3′ end of dystrobrevin-β there is a divergence point exactly at the 3′ end of dystrophin exon 75, indicating that the border of exon 75 is conserved. The C-terminal domain of dystrobrevin-α also joins exactly with the sequence homologous to dystrophin exon 77. Whether the other borders are also conserved needs to be confirmed by analysis of the genomic organization of the dystrobrevin gene, but at least seven of the fifteen borders are conserved and presumably others will also be conserved.
The biological role of dystrobrevin is unknown, although the Torpedo equivalent presumably plays a major role in the organization of post-synaptic structures. By analogy, it may play a major role in dystrophin associated structures such as the DAG. This is supported by the isolation of a cDNA encoding a partial sequence of the rabbit A 0 (94 kDa) which copurifies with the DAG complex (23) . A 0 was shown to be homologous to the Torpedo 87 kDa protein, and sequence comparison of dystrobrevin and rabbit A 0 indicates that at least one splice form of dystrobrevin is equivalent to rabbit A 0 . Interestingly, using anti-A 0 antibodies, western blot analysis detected two protein bands in rabbit skeletal muscle tissue, a 94 kDa and 62 kDa (23) , confirming that splice forms also exist in other species. Although previous results had shown that exon 74 and in some cases exon 73 were necessary for binding to the syntrophins (15, 16) , recent experiments demonstrate that dystrophin's exon 74 alone is sufficient for binding to the syntrophins (30) . In addition, the C-terminus of DRP (chromosome-6 dystrophin related protein) and Torpedo dystrobrevin were shown to be able to bind all three syntrophins in vitro (15, 16) . In Torpedo, the 87 kDa protein is known to associate with the 58 kDa syntrophin in a ternary complex with dystrophin. These results suggest that dystrobrevin (A 0 ) binds syntrophin through the region that is homologous to dystrophin's exon 74. It is interesting to note that one of the splice forms cloned, dystrobrevin-δ, does not encode exon 74, and therefore is probably not involved in association with syntrophin. Therefore, the existence of the different splice forms and their tissue distribution probably reflects different functions of dystrobrevin depending on the tissue need.
MATERIALS AND METHODS

cDNA library screening
An initial hybridization probe was prepared by PCR amplification of 400 ng of human adult brain cDNA library lysate with primers amplifying a 61 bp fragment from the previously described EST00891 clone (28) (5′-TCGCATCCGACTCTC-CACCTACAG-3′ and 5′-GCATTTCTTCTGAACAAACCTA-AGCTT-3′). Following separation by electrophoresis on a low-melt agarose gel (NuSieve GTG, FMC) and band excision, 30-40 ng of DNA were amplified by PCR in the presence of 10 µCi of [α 32 P]dCTP. An unamplified human adult brain cDNA library, prepared as described (31) , was screened by hybridization (32) with the radiolabeled EST00891 amplification product (10 6 cpm/ml). Following three 20 min washes at 55_C in 0.0015 M NaCl, 0.015 M Na Citrate, (pH 7.0) and 0.1% SDS, positively hybridizing plaques were purified and phage DNA was prepared (32) . The isolated 1.7 kb cDNA clone was digested with EcoRI, and subcloned into Bluescript II SK + plasmid vector (Stratagene). Subsequent screenings of unamplified human adult brain and human adult muscle cDNA libraries were performed similarly with three different hybridization probes (Fig. 3) . Hybridization probe 89A was prepared by PCR amplification with primers amplifying a 808 bp fragment, corresponding to the 5′ translated end of dystrobrevin (5′-TCGCATCCGACTCTCCACCTAC-AG-3′ and 5′-CACCGGCATGTCCCCTCCAGAAGC-3′), hybridization probe 89B was prepared by PCR amplification with primers amplifying a 187 bp fragment, corresponding to the middle of the translated region of full length dystrobrevin (5′-CCCAGAGACTTCGGCTAGAGC-3′ and 5′-TAGCTTCA-TGAGACCCTCC-3′), and hybridization probe 89C was prepared by PCR amplification with primers amplifying a 281 bp fragment, corresponding to the 3′ translated end of full length dystrobrevin (5′-CAGACACACCATCAGCAGGTC-3′ and 5′-GATCCTCAAACTGAGTCCGTG-3′). All probes were hybridized as above.
Sequencing and database search
The entire sequence of the cDNAs on both DNA strands was determined with an Applied Biosystems automated sequencer using Taq DNA polymerase cycle sequencing. Acquired data was analyzed using Sequencher software (Genecodes, AnnArbor) or Genetics Computer Group software (Program manual for the GCG Package, Version 8, September 1994). The cDNA and deduced amino acid sequences were compared with the GenBank database on the National Center for Biotechnology Information BLAST Network Service (33) .
Northern blot analysis
Hybridization probes were prepared as described above by PCR amplification using the following primer sets: 89D (5′-CGA-CATGGTTACGGAGGATGC-3′and 5′-CCTATGCACCTACAA-ATCTG-3′), 89E (5′-GGTGGATGCGTCTAGATGGATAAC-3′ and 5′-CGTAGGCCAATCTCTGTGGTGACAG-3′), 89F (5′-GC-AGGTCTCAACTAACAGTGGAGG-3′ and 5′-GGTTAGCTTC-TGAGTGCTGTGGG-3′). The five hybridization probes were used to serially hybridize to human multiple-tissue Northern blots (Clontech). Hybridization was performed according to the manufacturer's protocol. The filter was exposed to film (Kodak) for subsequent detection of the positively hybridizing transcripts by autoradiography.
Reverse transcription (RT)-PCR
A quantity of 10 µg of total mRNA was used for reverse transcription with 40 U of Superscript II RNaseH -Reverse Transcriptase (Gibco-BRL) in 50 mM Tris-HCl (pH 8.3), 40 mM KCl, 1 mM DTT, 6 mM MgCl 2 and 0.1 mM oligo dT (Gibco-BRL) in a total volume of 20 µl. PCR amplification was performed in a final volume of 25 µl using 1 µl from a 1:40 dilution of the reverse transcribed template and 50 ng of each primer at 94_C for 4 min, and 25 cycles of 94_C for 1 min, 60_C for 1 min, 72_C for 1 min. One fifth of each reaction were examined by agarose gel electrophoresis, and the PCR products were subsequently re-amplified by PCR and 300 ng of the amplification product was used for direct sequencing.
Antibody design and purification
A peptide CAERRQLFAEMRAQDLDR corresponding to amino acids 13-29 of dystrobrevin plus an N-terminal cysteine was synthesized and purified by high performance liquid chromatography (Quality Controlled Biochemicals, Inc., Hopkinton, MA). It was suspended in saline and emulsified by mixing with Freund's Adjuvant, and then injected into three subcutaneous dorsal sites into rabbits for polyclonal antibody production (Quality Controlled Biochemicals, Inc., Hopkinton, MA). The crude sera was verified for specific activity against the peptide by ELISA assay (data not shown). Affinity purification was accomplished using a peptide coupled sulfo-link gel column and elution of the antibody according to the manufacturer's protocol (Pierce).
Immunoblot analysis
Human brain and placenta tissues samples were frozen in liquid nitrogen, pulverized and then resuspended in 1 ml of either loading buffer (10% sodium dodecyl sulfate (SDS), 50 mM dithiothreitol (DTT), 10 mM EDTA, 0.1 M TRIS, pH 8.0, and 0.001% bromophenol blue) or sample buffer (0.0625 M Tris, pH 6.8, 10% glycerin (v/v), 2% SDS (wt/v), 10 mM EDTA, 50 mM DTT, 0.29 M β-mercaptoethanol, 5 µg/ml pepstatin, 40 µg/ml PMSF, 1.5 µg/ml aprotinin, 0.2 mM iodoacetamide, 0.8 mM benzamidine), boiled for 5 min, sonicated for 45 s, and centrifuged for 5 min at 13 K to remove debris. The human samples and purified Torpedo membrane sample were separated by 7.5% or 10% SDS-PAGE (34) and were transferred to nitrocellulose (0.45 µm; Schleicher and Schuell). The transfer was carried out in 250 mM glycine, 25 mM TRIS, pH 8.4, 0.1% SDS, and 20% (v/v) methanol for 2 h at 65 V at 4_C (35) . Nitrocellulose transfers were blocked for 1 h in TBST containing 5% nonfat dry milk at room temperature. Primary antibodies were diluted into TBST and used at dilutions of 1/5000 (affinity purified Ab PEP89) and 1/1000 dilution (ascites IgM 24H3, a monoclonal against Torpedo 87 kDa) (9) . After washing three times for 15 min each in PBS, filters were blocked for 15 min in TBST containing 5% nonfat dry milk, filters were incubated for 1 h with secondary antibodies diluted 1:10000 in PBS. Filters were washed again three times 15 min in TBST, and incubated for 1 min in chemiluminescence reagents according to the manufacturer's instruction (Amersham), and exposed to film (Kodak) for detection by autoradiography. 
